EUVIMEDEUVIMED entdecken
Crossref

Anticoagulation after pulmonary vein isolation for atrial fibrillation: Associations with CHA₂DS₂‐VASc score, sex, and rhythm

Tom Kai Ming Wang iD, Nicholas Chan, Aro D Arockiam, Paul C Cremer, Mohamed Kanj, Bryan Baranowski, Walid Saliba, Ayman Hussein, Oussama M Wazni, Wael A Jaber, Other members of the Cleveland Clinic Cardiovascular Imaging and Electrophysiology Collaborative Group

Journal of Cardiovascular Electrophysiology · 2023

DOI: 10.1111/jce.15848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2023. Verfasst von Tom Kai Ming Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guidelines recommend using the CHA₂DS₂‐VASc score to determine anticoagulation decisions in atrial fibrillation (AF) patients, including those who undergo pulmonary vein isolation (PVI), however this may not consistently occur in the real‐world setting because of other clinical factors. We sought to evaluate the anticoagulation prescription rates patterns in AF patients 1 year PVI at our institution. Consecutive AF patients undergoing PVI in our prospective registry during 2014−2018 who were alive at 1‐year post‐PVI were studied. Anticoagulation prescription rates at this time‐point were adjudicated, and correlated to CHA₂DS₂‐VASc score, sex, and heart rhythm status at 1 year. Amongst 4596 patients undergoing PVI, mean age was 64.2 ± 10.0 years, 1328 (28.9%) were female, and based on CHA₂DS₂‐VASc score anticoagulation was not indicated, can be considered and indicated in 872 (19.0%), 1183 (25.7%), and 2541 (55.3%) patients, respectively. At 1‐year after PVI, 3504 (76.2%) patients were on anticoagulation, and 792 (17.2%) had recurrence of AF. Anticoagulation was continued in over half of AF patients without classic CHA₂DS₂‐VASc indication particularly in those with AF recurrence and women, while they were mildly under‐prescribed in those with indication, especially for those without AF recurrence and men. In a large real world cohort of patients after PVI, anticoagulation prescription is not solely depending on the CHA₂DS₂‐VASc score and sex, but also heart rhythm status and other clinical or imaging factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPulmonary VeinsCatheter AblationMaleHumansFemaleMiddle AgedAgedRisk AssessmentBlood CoagulationRecurrenceTreatment Outcome

Stichwörter der Autor:innen

ablationanticoagulantsatrial fibrillationpulmonary vein isolation

Autor:innen und Institutionen

  • Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Section of Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Tom Kai Ming Wang

Zitieren

APA

Wang, T. K. M., Chan, N., Arockiam, A. D., Cremer, P. C., Kanj, M., Baranowski, B., Saliba, W., Hussein, A., Wazni, O. M., Jaber, W. A., & Other members of the Cleveland Clinic Cardiovascular Imaging and Electrophysiology Collaborative Group (2023). Anticoagulation after pulmonary vein isolation for atrial fibrillation: Associations with CHA₂DS₂‐VASc score, sex, and rhythm. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.15848

Vancouver

Wang TKM, Chan N, Arockiam AD, Cremer PC, Kanj M, Baranowski B, et al. Anticoagulation after pulmonary vein isolation for atrial fibrillation: Associations with CHA₂DS₂‐VASc score, sex, and rhythm. Journal of Cardiovascular Electrophysiology. 2023. doi:10.1111/jce.15848

BibTeX
@article{Wang2023,
  author = {Wang, Tom Kai Ming and Chan, Nicholas and Arockiam, Aro D and Cremer, Paul C and Kanj, Mohamed and Baranowski, Bryan and Saliba, Walid and Hussein, Ayman and Wazni, Oussama M and Jaber, Wael A and Other members of the Cleveland Clinic Cardiovascular Imaging and Electrophysiology Collaborative Group, Other members of the Cleveland Clinic Cardiovascular Imaging and Electrophysiology Collaborative Group},
  title = {Anticoagulation after pulmonary vein isolation for atrial fibrillation: Associations with CHA₂DS₂‐VASc score, sex, and rhythm},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2023},
  doi = {10.1111/jce.15848}
}
Kostenlos starten →